Industry & Policy

Anthropic acquires one-person biotech startup, develops drug with Claude

Original article in Korean앤트로픽, 1인 신약 개발사 인수...클로드로 직접 치료제 개발

Outlet: AI Times
Published: Oct 30, 2026
Importance: 4/5

Summary

Anthropic acquired Mithril Medicine, a biotech startup run by one founder, and is developing drugs using Claude. The founder managed 11 external research labs with Claude and achieved animal trial results for a rare muscle disorder treatment in less than 18 months.

#anthropic#claude#biotech

Read the originalaitimes.com · in Korean

See all →

Jun 9

OpenAI files confidentially for IPO, following Anthropic

OpenAI submitted a confidential Form S-1 filing with the SEC, following Anthropic's IPO filing from the previous week. The confidential filing means certain details such as executive compensation and business risks remain nonpublic.

TechCrunch

Jul 7

Samsung Electronics reports Q2 operating profit of KRW 89.4 trillion, up 1810% year-over-year

Samsung Electronics recorded a second-quarter operating profit of KRW 89.4 trillion, marking its third consecutive record quarter. The result represents a 1,810% increase from the same period last year, with revenue reaching KRW 171 trillion, up 129.3% annually. AI semiconductor demand drove the exceptional growth.

AI Times

Oct 6

Google limits free Gemini access starting October 9th

Starting October 9th, free Google Gemini users will be limited to the Flash Lite model. Access to the standard Flash model requires a $4.99 monthly Google AI Plus subscription, which will also stop including Gemini Pro. Top-tier Gemini Pro and Deep Think reasoning will be restricted to Google AI Pro or Ultra subscribers.

The Verge AI +1 more

Oct 7

DeepSeek nearly doubles pre-IPO funding to up to $15 billion

DeepSeek raised its pre-IPO funding target from $7.4 billion to between $12 billion and $15 billion as investor interest surged. CATL and Tencent Holdings are the lead investors.